Insider · CIK 0002066576
Peter J. Weiler
Files at EDSA (Edesa Biotech, Inc.). First filing -, latest -.
Peter J. Weiler files SEC Form 4 as CFO at EDSA (Edesa Biotech, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Peter J. Weiler has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +64,609 | $0.00 | $0 | 129,609 | May 29, 2026 |
| May 29, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +65,000 | $0.00 | $0 | 65,000 | Jun 2, 2025 |
Questions about Peter J. Weiler
Answered from the filings on this page, as of the latest one.
Is Peter J. Weiler buying or selling?
Peter J. Weiler has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Peter J. Weiler's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter J. Weiler has 0.
Where does Peter J. Weiler file Form 4?
Peter J. Weiler has filed Form 4 at EDSA (Edesa Biotech, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.